Your browser doesn't support javascript.
loading
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Cazzaniga, M E; Pinotti, G; Montagna, E; Amoroso, D; Berardi, R; Butera, A; Cagossi, K; Cavanna, L; Ciccarese, M; Cinieri, S; Cretella, E; De Conciliis, E; Febbraro, A; Ferraù, F; Ferzi, A; Fiorentini, G; Fontana, A; Gambaro, A R; Garrone, O; Gebbia, V; Generali, D; Gianni, L; Giovanardi, F; Grassadonia, A; Leonardi, V; Marchetti, P; Melegari, E; Musolino, A; Nicolini, M; Putzu, C; Riccardi, F; Santini, D; Saracchini, S; Sarobba, M G; Schintu, M G; Scognamiglio, G; Spadaro, P; Taverniti, C; Toniolo, D; Tralongo, P; Turletti, A; Valenza, R; Valerio, M R; Vici, P; Clivio, L; Torri, V.
Affiliation
  • Cazzaniga ME; Research Unit Phase I Trials, ASST Monza, Monza, Italy; Oncology Unit, ASST Monza, Italy. Electronic address: marina.cazzaniga@asst-monza.it.
  • Pinotti G; Medical Oncology, ASST Sette Laghi "Ospedale di Circolo e Fondazione Macchi, Varese, VA, Italy.
  • Montagna E; Medical Senology Division, IEO, Milan, Italy.
  • Amoroso D; Medical Oncology, Ospedale Della Versilia, Lido di Camaiore, IT, Italy.
  • Berardi R; Medical Oncology, A. Ospedaliero-universitaria Ospedali Riuniti, Ancona, IT, Italy.
  • Butera A; Medical Oncology, Ospedale San Giovanni di Dio, Agrigento, IT, Italy.
  • Cagossi K; Medical Oncology, Ospedale Ramazzini, Carpi, IT, Italy.
  • Cavanna L; Medical Oncology, Azienda Ospedaliera Piacenza, Piacenza, IT, Italy.
  • Ciccarese M; Medical Oncology, Ospedale Vito Fazzi, Lecce, IT, Italy.
  • Cinieri S; Medical Oncology, ASL Brindisi, Brindisi, Italy.
  • Cretella E; Medical Oncology, Ospedale Bolzano, IT, Italy.
  • De Conciliis E; Medical Oncology, ASL Asti, Asti, IT, Italy.
  • Febbraro A; Medical Oncology, Ospedale S. Cuore di Gesù Fatebenefratelli, Benevento, Italy.
  • Ferraù F; Medical Oncology, Osp Taormina, Taormina, IT, Italy.
  • Ferzi A; Medical Oncology, A.S.S.T. Ovest Milanese, Legnano, IT, Italy.
  • Fiorentini G; Medical Oncology, Ospedale San Salvatore, Pesaro, Italy.
  • Fontana A; Medical Oncology, Az. Ospedaliero-Universitaria, Pisana, IT, Italy.
  • Gambaro AR; Medical Oncology, ASST Fatebenefratelli, Sacco, IT, Italy.
  • Garrone O; Medical Oncology, A.O. S. Croce e Carle, Cuneo, Italy.
  • Gebbia V; Medical Oncology, Ospedale La Maddalena, Palermo, IT, Italy.
  • Generali D; Medical Oncology, Istituti Ospitalieri Cremona, Cremona, IT, Italy.
  • Gianni L; Medical Oncology, Azienda USL Romagna, U.O. di Oncologia Rimini, Cattolica, IT, Italy.
  • Giovanardi F; Medical Oncology, Ospedale Civile, Guastalla, IT, Italy.
  • Grassadonia A; Medical Oncology, P.O. SS Annunziata -ASL2 Lanciano-Vasto, Chieti, IT, Italy.
  • Leonardi V; Medical Oncology, Ospedale Civico, Palermo, IT, Italy.
  • Marchetti P; Medical Oncology, A.O. Sant'Andrea, Roma, IT, Italy.
  • Melegari E; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Musolino A; Medical Oncology, Azienda Ospedaliero-Universitaria di Parma, IT, Italy.
  • Nicolini M; Medical Oncology, Azienda USL Romagna, U.O. di Oncologia Rimini, Cattolica, IT, Italy.
  • Putzu C; Medical Oncology, A. Ospedaliera-Universitaria, Sassari, IT, Italy.
  • Riccardi F; Medical Oncology, A. Ospedaliera Antonio Cardarelli, Napoli, IT, Italy.
  • Santini D; Medical Oncology Università Campus Bio-Medico, Roma, IT, Italy.
  • Saracchini S; Medical Oncology, Az. Osp. Santa Maria Degli Angeli, Pordenone, IT, Italy.
  • Sarobba MG; Medical Oncology, Ospedale San Francesco, Nuoro, IT, Italy.
  • Schintu MG; Medical Oncology, Osp Giovanni Paolo II, Olbia, IT, Italy.
  • Scognamiglio G; Medical Oncology, Ospedale Valduce, Como, IT, Italy.
  • Spadaro P; Medical Oncology, Casa di Cura Villa Salus, Messina, IT, Italy.
  • Taverniti C; Medical Oncology, A.O.U. Città Della Salute e Della Scienza, Osp. Molinette, Torino, IT, Italy.
  • Toniolo D; Medical Oncology, ASST Rhodense 3 Ospedale di Circolo Rho, IT, Italy.
  • Tralongo P; Medical Oncology, Osp. Umberto I, Siracusa, IT, Italy.
  • Turletti A; Medical Oncology, P.O. Martini, Torino, IT, Italy.
  • Valenza R; Medical Oncology, P.O. Vittorio Emanuele, Gela, IT, Italy.
  • Valerio MR; Medical Oncology, A.O.U. Policlinico Paolo Giaccone, Palermo, IT, Italy.
  • Vici P; Medical Oncology, B, INT Regina Elena, Roma, IT, Italy.
  • Clivio L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy.
  • Torri V; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy.
Breast ; 48: 7-16, 2019 Dec.
Article de En | MEDLINE | ID: mdl-31470257
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Antinéoplasiques Type d'étude: Observational_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Antinéoplasiques Type d'étude: Observational_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article